e-learning
resources
Paris 2018
Tuesday, 18.09.2018
CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic variant in MMP2 increases the risk to develop autoantibodies in patients with Hypersensitivity Pneumonitis
I. Buendia Roldán (Ciudad de Mexico, Mexico), L. Santiago Ruiz (Ciudad de Mexico, Mexico), G. Perez Rubio (Ciudad de Mexico, Mexico), M. Mejia (Ciudad de Mexico, Mexico), M. Montaño (Ciudad de Mexico, Mexico), R. Falfan Valencia (Ciudad de Mexico, Mexico)
Source:
International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Session:
CTD-ILD and hypersensitivity pneumonitis: risk stratification and management
Session type:
Oral Presentation
Number:
3819
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Buendia Roldán (Ciudad de Mexico, Mexico), L. Santiago Ruiz (Ciudad de Mexico, Mexico), G. Perez Rubio (Ciudad de Mexico, Mexico), M. Mejia (Ciudad de Mexico, Mexico), M. Montaño (Ciudad de Mexico, Mexico), R. Falfan Valencia (Ciudad de Mexico, Mexico). Genetic variant in MMP2 increases the risk to develop autoantibodies in patients with Hypersensitivity Pneumonitis. 3819
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Asbestosis
Related content which might interest you:
HLA class II alleles and haplotypes are associated to the presence autoantibodies and mortality in Hypersensitivity Pneumonitis patients.
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
A
BTNL2
gene variant confers to sarcoidosis susceptibility by an increased risk towards the chronic form of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 148s
Year: 2006
A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis
Source: Eur Respir J, 56 (2) 1901380; 10.1183/13993003.01380-2019
Year: 2020
Cancers and opportunistic infections in sarcoidosis are associated with an increased frequency of BTNL2 variants
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Increased disease severity and mortality associated with the Bronchiectasis-GORD phenotype
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation study
Source: Eur Respir J, 59 (2) 2003979; 10.1183/13993003.03979-2020
Year: 2022
Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis
Source: Eur Respir J 2013; 41: 888-900
Year: 2013
Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Mannose binding lectin - HYPD allele is associated with frequent exacerbation in COPD patients
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Genetic polymorphisms in MMP9 and TIMP2 genes and risk of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Is the BTNL2 genotype associated with specific HLA-DRB1 and DRB3/4/5 alleles in Danish sarcoidosis patients?
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015
The
MUC5B
promoter risk allele for idiopathic pulmonary fibrosis predisposes to asbestosis
Source: Eur Respir J, 55 (4) 1902361; 10.1183/13993003.02361-2019
Year: 2020
Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Role of AQP5 polymorphisms in predisposition to asthma
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
Angiopoietin-2 gene polymorphism as prognostic factor in caucasians with idiopathic pulmonary fibrosis
Source: International Congress 2014 – ILDs 1
Year: 2014
High levels of vascular endothelial growth factor–C and D are associated with disease severity of hypersensitivity pneumonitis
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Combinations of T-bet and HLX1 gene variants significantly increase childhood asthma risk
Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy
Year: 2008
TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis
Source: International Congress 2016 – Sarcoidosis
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept